Theravance Biopharma Announces Presentations at Upcoming Investor Conferences

On February 18, 2020 Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, reported that it will webcast Management presentations (Press release, Theravance, FEB 18, 2020, View Source [SID1234554473]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SVB Leerink 9th Annual Global Healthcare Conference at 11:30 a.m. ET (8:30 a.m. PT/4:30 p.m. GMT) on Wednesday, February 26, 2020

Cowen and Company 40th Annual Health Care Conference at 1:30 p.m. ET (10:30 a.m. PT/6:30 p.m. GMT) on Monday, March 2, 2020
Webcasts of the presentations may be accessed by visiting the Investor Relations section of Theravance Biopharma’s website at www.theravance.com, under the Presentations and Events tab. Replays of the webcasts will be archived on the Company’s website for at least 30 days.